# SAL0137 Phase I Study in in Healthy Participants With or Without Elevated Lp(a)

> **NCT07745114** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Shenzhen Salubris Pharmaceuticals Co., Ltd.** · enrollment: 144 (estimated)

## Conditions studied

- Healthy Participants
- Elevated Lp(a)

## Interventions

- **DRUG:** Single Ascending Dose
- **DRUG:** Single Ascending Dose
- **DRUG:** Once Daily (QD), Multiple Ascending Dose (MAD)
- **DRUG:** Once Daily (QD), Multiple Ascending Dose (MAD)

## Key facts

- **NCT ID:** NCT07745114
- **Lead sponsor:** Shenzhen Salubris Pharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-01-04
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2026-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07745114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07745114, "SAL0137 Phase I Study in in Healthy Participants With or Without Elevated Lp(a)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07745114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*